AzTrials
AzTrials

Health StatusNCT07249086

Cohort of Nursing Homes

An observational study of Health Status, run by Institute of Hematology & Blood Diseases Hospital, China at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study was to establish cohorts of elderly people in hospital care and elderly people in home care. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Health Status
How many people
1,500 participants
Where
1 siteChina
Study dates
30 Nov 2023to 31 Dec 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Elderly people residing in retirement communities with medical facilities and people receiving home care.

Who may be able to join

  • Voluntarily participated in this study and provided signed informed consent forms.
  • Both male and female.
  • Age 60 years old and above.

Who cannot join

  • Unable to participate in physical examinations due to being bedridden or having limited mobility.
  • Unable to communicate effectively.
  • People cannot participate for other reasons.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • Institute of Hematology & Blood Diseases Hospital

    Tianjin, 300000

    Zhen Song, +86 02223909051, cir@ihcams.ac.cn

    Recruiting

Other trials in China

About this study

Official title: Cohort of Nursing Homes (CNH)

The goal of this observational study was to establish cohorts of elderly people in hospital care and elderly people in home care.

Read the detailed description

This is an observational study that aims to establish a cohort of elderly people through the nursing homes in the area where the "Tianjin Base" is located, and to scientifically observe and measure the changes and improvements in the health of the elderly population brought about by the new medical care model, such as large-scale elderly care complexes, in order to provide a platform for the study of the health of the elderly population, and thus carry out the exploration of a new model of health promotion. Exploration of new models of health promotion. By comparing the elderly care complex with the home health care mode, and exploring the promotion of "active health" awareness of the elderly through intervention, the investigators will explore the appropriate elderly care mode for different conditions of the elderly population, and explore the advantages of the centralized elderly care mode to be promoted to the home elderly population, so as to establish an elderly care mode that is suitable for the elderly population in Tianjin.

Conditions
Health Status
Keywords
Health status of elderly people, Elderly (people aged 60 or more)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07249086
Study groupRoleWhat they receive
Elderly people in medical-nursing careThe elderly people residing in retirement communities with medical facilities
Elderly people in home careThe elderly people receiving home care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health status of elderly people

    The diseases status of elderly people, including chronic diseases, cancers, and priority diseases.

    Measured: The diseases status of elderly people will be assessed at baseline and at follow-up visits every 3 to 5 years.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2025
  2. Study start30 Nov 2023
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07249086
Sponsor's protocol ID
QTJC2023072
Status last verified
Nov 2024
First submitted
1 Aug 2025
Last updated
25 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Health Status, run by Institute of Hematology & Blood Diseases Hospital, China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health status of elderly people (time frame: The diseases status of elderly people will be assessed at baseline and at follow-up visits every 3 to 5 years.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in